cbdMD (NYSEAMERICAN:YCBD) released its quarterly earnings data on Thursday. The company reported $0.45 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.15) by $0.60, Fidelity Earnings reports. The company had revenue of $10.41 million for the quarter.
YCBD stock traded down $0.01 during trading on Friday, reaching $1.14. 7,778 shares of the company were exchanged, compared to its average volume of 1,265,310. cbdMD has a twelve month low of $0.99 and a twelve month high of $7.24.
A number of research firms recently issued reports on YCBD. Cantor Fitzgerald began coverage on shares of cbdMD in a research report on Thursday, November 7th. They set a “neutral” rating for the company. Benchmark lowered their price objective on shares of cbdMD from $9.00 to $7.00 and set a “speculative buy” rating for the company in a research report on Thursday, December 19th.
cbdMD, Inc produces and distributes various cannibidiol (CBD) products in the United States. It operates through three segments: Products, Licensing, and Entertainment. The Products segment produces and markets CBD tinctures, capsules, gummies, bath bombs, vape oils, topical creams, and animal treats and oils under the cdbMD brand.
Recommended Story: S&P 500 Index
Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.